Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Sagara

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Breast Cancer (Tokyo, Japan)|May 29, 2026
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017Kiyo Tanaka, Akihiko Shimomura, Makoto Ishitobi, et al.
Breast Cancer (Tokyo, Japan)|June 23, 2025
Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancerTetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki, et al.
Breast Cancer (Tokyo, Japan)|May 20, 2025
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancerTetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki, et al.
Breast Cancer (Tokyo, Japan)|April 22, 2021
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 editionTatsunori Shimoi, Shigenori E Nagai, Tetsuhiro Yoshinami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 18, 2025
Deep Learning for Cardiac Overload Estimation　- Predicting B-Type Natriuretic Peptide (BNP) Levels From Heart Sounds and ElectrocardiogramShimpei Ogawa, Masanobu Ishii, Shumpei Saito, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2020
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 editionTatsunori Shimoi, Shigenori E Nagai, Tetsuhiro Yoshinami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II TrialIan E Krop, Norikazu Masuda, Toru Mukohara, et al.
Psychiatry and Clinical Neurosciences|March 12, 2024
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study)Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter StudyHitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Breast Cancer (Tokyo, Japan)|May 29, 2026
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017Kiyo Tanaka, Akihiko Shimomura, Makoto Ishitobi, et al.
Breast Cancer (Tokyo, Japan)|June 23, 2025
Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancerTetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki, et al.
Breast Cancer (Tokyo, Japan)|May 20, 2025
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancerTetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki, et al.
Breast Cancer (Tokyo, Japan)|April 22, 2021
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 editionTatsunori Shimoi, Shigenori E Nagai, Tetsuhiro Yoshinami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 18, 2025
Deep Learning for Cardiac Overload Estimation　- Predicting B-Type Natriuretic Peptide (BNP) Levels From Heart Sounds and ElectrocardiogramShimpei Ogawa, Masanobu Ishii, Shumpei Saito, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2020
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 editionTatsunori Shimoi, Shigenori E Nagai, Tetsuhiro Yoshinami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II TrialIan E Krop, Norikazu Masuda, Toru Mukohara, et al.
Psychiatry and Clinical Neurosciences|March 12, 2024
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study)Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter StudyHitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 14